The effects of hypertension as an existing comorbidity on mortality rate in patients with COVID-19 A systematic review and meta-analysis

Elena Whiteman
doi: https://doi.org/10.1101/2020.11.16.20149377

Article usage

Article usage: November 2020 to January 2025

AbstractFullPdf
Nov 20204501064
Dec 2020214631
Jan 20211711549
Feb 2021150931
Mar 20211301825
Apr 20211301711
May 20211151539
Jun 2021781117
Jul 202164824
Aug 2021621026
Sep 202143519
Oct 202150254
Nov 202142222
Dec 20212659
Jan 202228718
Feb 20221902
Mar 20222319
Apr 202238211
May 202231012
Jun 202227011
Jul 20221702
Aug 20222116
Sep 20222717
Oct 20222407
Nov 20221816
Dec 202218111
Jan 20232314
Feb 20231627
Mar 20231002
Apr 20232414
May 202311111
Jun 20231044
Jul 20231013
Aug 202321137
Sep 20231547
Oct 20231402
Nov 20232075
Dec 20231701
Jan 20241205
Feb 202422211
Mar 20241418
Apr 202413440
May 20241422
Jun 20241503
Jul 2024915
Aug 202424510
Sep 202416615
Oct 20241276
Nov 20241609
Dec 202415310
Jan 20251026
Back to top
Posted November 17, 2020.
Download PDF
Data/Code
Email
The effects of hypertension as an existing comorbidity on mortality rate in patients with COVID-19 A systematic review and meta-analysis
Elena Whiteman
medRxiv 2020.11.16.20149377; doi: https://doi.org/10.1101/2020.11.16.20149377
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area